{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:10:12Z","timestamp":1765667412606,"version":"3.37.3"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12325-023-02430-3","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T17:03:11Z","timestamp":1674666191000},"page":"1494-1529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Human Albumin Infusion for the Management of Liver Cirrhosis and Its Complications: An Overview of Major Findings from Meta-analyses"],"prefix":"10.1007","volume":"40","author":[{"given":"Xiaojie","family":"Zheng","sequence":"first","affiliation":[]},{"given":"Zhaohui","family":"Bai","sequence":"additional","affiliation":[]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Fernando G.","family":"Romeiro","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Mancuso","sequence":"additional","affiliation":[]},{"given":"Cyriac A.","family":"Philips","sequence":"additional","affiliation":[]},{"given":"Yu J.","family":"Wong","sequence":"additional","affiliation":[]},{"given":"Filipe G.","family":"Nery","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9448-6739","authenticated-orcid":false,"given":"Xingshun","family":"Qi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"issue":"10308","key":"2430_CR1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/s0140-6736(21)01374-x","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359\u201376. https:\/\/doi.org\/10.1016\/s0140-6736(21)01374-x.","journal-title":"Lancet"},{"issue":"9930","key":"2430_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/s0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749\u201361. https:\/\/doi.org\/10.1016\/s0140-6736(14)60121-5.","journal-title":"Lancet"},{"issue":"5","key":"2430_CR3","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","volume":"63","author":"M Bernardi","year":"2015","unstructured":"Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol. 2015;63(5):1272\u201384. https:\/\/doi.org\/10.1016\/j.jhep.2015.07.004.","journal-title":"J Hepatol"},{"key":"2430_CR4","doi-asserted-by":"publisher","unstructured":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245\u2013266. https:\/\/doi.org\/10.1016\/s2468-1253(19)30349-8","DOI":"10.1016\/s2468-1253(19)30349-8"},{"issue":"6","key":"2430_CR5","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.jhep.2022.03.005","volume":"76","author":"P Caraceni","year":"2022","unstructured":"Caraceni P, O\u2019Brien A, Gines P. Long-term albumin treatment in patients with cirrhosis and ascites. J Hepatol. 2022;76(6):1306\u201317. https:\/\/doi.org\/10.1016\/j.jhep.2022.03.005.","journal-title":"J Hepatol"},{"issue":"1","key":"2430_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D'Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217\u201331. https:\/\/doi.org\/10.1016\/j.jhep.2005.10.013.","journal-title":"J Hepatol"},{"issue":"5","key":"2430_CR7","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.26338","volume":"58","author":"R Garcia-Martinez","year":"2013","unstructured":"Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. 2013;58(5):1836\u201346. https:\/\/doi.org\/10.1002\/hep.26338.","journal-title":"Hepatology"},{"issue":"6","key":"2430_CR8","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","volume":"69","author":"M Bernardi","year":"2020","unstructured":"Bernardi M, Angeli P, Claria J, Moreau R, Gines P, Jalan R, et al. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut. 2020;69(6):1127\u201338. https:\/\/doi.org\/10.1136\/gutjnl-2019-318843.","journal-title":"Gut"},{"issue":"2","key":"2430_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"P Angeli","year":"2018","unstructured":"Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J, Krag A, Laleman W, Gines P. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406\u201360. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.024.","journal-title":"J Hepatol"},{"key":"2430_CR10","doi-asserted-by":"publisher","unstructured":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol. 2014;61(3):642\u2013659. https:\/\/doi.org\/10.1016\/j.jhep.2014.05.042","DOI":"10.1016\/j.jhep.2014.05.042"},{"issue":"5","key":"2430_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.7326\/0003-4819-126-5-199703010-00006","volume":"126","author":"DJ Cook","year":"1997","unstructured":"Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126(5):376\u201380. https:\/\/doi.org\/10.7326\/0003-4819-126-5-199703010-00006.","journal-title":"Ann Intern Med"},{"issue":"23","key":"2430_CR12","doi-asserted-by":"publisher","first-page":"34703","DOI":"10.18632\/oncotarget.9157","volume":"7","author":"X Qi","year":"2016","unstructured":"Qi X, Zhao Y, Li H, Guo X, Han G. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses. Oncotarget. 2016;7(23):34703\u201351. https:\/\/doi.org\/10.18632\/oncotarget.9157.","journal-title":"Oncotarget"},{"key":"2430_CR13","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https:\/\/doi.org\/10.1136\/bmj.j4008.","journal-title":"BMJ"},{"issue":"4","key":"2430_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Sch\u00fcnemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380\u20132. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.09.011.","journal-title":"J Clin Epidemiol"},{"issue":"7650","key":"2430_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD.","journal-title":"BMJ"},{"issue":"5","key":"2430_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.21037\/amj.2017.04.08","volume":"2","author":"D Zou","year":"2017","unstructured":"Zou D, Han T, Deng H, Shao X, Guo X, Qi X. Hypoxia-inducible factors in cancer: an overview of major findings from meta-analyses. AME Med J. 2017;2(5):48.","journal-title":"AME Med J"},{"key":"2430_CR17","doi-asserted-by":"publisher","first-page":"100547","DOI":"10.1016\/j.aohep.2021.100547","volume":"26","author":"DB Shrestha","year":"2021","unstructured":"Shrestha DB, Budhathoki P, Sedhai YR, Baniya R, Awal S, Yadav J, et al. Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: a systematic review and meta-analysis. Ann Hepatol. 2021;26:100547. https:\/\/doi.org\/10.1016\/j.aohep.2021.100547.","journal-title":"Ann Hepatol"},{"key":"2430_CR18","doi-asserted-by":"publisher","first-page":"100541","DOI":"10.1016\/j.aohep.2021.100541","volume":"26","author":"B Is","year":"2021","unstructured":"Is B, Bombassaro IZ, Tovo CV, de Mattos \u00c2Z, Ahlert M, Chiesa T, et al. Albumin in the management of hepatic encephalopathy: a systematic review and meta-analysis. Ann Hepatol. 2021;26:100541. https:\/\/doi.org\/10.1016\/j.aohep.2021.100541.","journal-title":"Ann Hepatol"},{"issue":"12","key":"2430_CR19","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1111\/jgh.14791","volume":"34","author":"GS Le\u00e3o","year":"2019","unstructured":"Le\u00e3o GS, John Neto G, Jotz RDF, Mattos AAD, Mattos \u00c2ZD. Albumin for cirrhotic patients with extraperitoneal infections: a meta-analysis. J Gastroenterol Hepatol (Australia). 2019;34(12):2071\u20136. https:\/\/doi.org\/10.1111\/jgh.14791.","journal-title":"J Gastroenterol Hepatol (Australia)"},{"issue":"3","key":"2430_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/jgh.15253","volume":"36","author":"BB Sandi","year":"2021","unstructured":"Sandi BB, Le\u00e3o GS, de Mattos AA, de Mattos \u00c2Z. Long-term albumin administration in patients with cirrhosis and ascites: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2021;36(3):609\u201317. https:\/\/doi.org\/10.1111\/jgh.15253.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"2430_CR21","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/hep.24786","volume":"55","author":"M Bernardi","year":"2012","unstructured":"Bernardi M, Caraceni P, Navickis RJ, Wilkes MM. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012;55(4):1172\u201381. https:\/\/doi.org\/10.1002\/hep.24786.","journal-title":"Hepatology"},{"issue":"2","key":"2430_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/jgh.13421","volume":"32","author":"F K\u00fctting","year":"2017","unstructured":"K\u00fctting F, Schubert J, Franklin J, Bowe A, Hoffmann V, Demir M, et al. Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis. J Gastroenterol Hepatol. 2017;32(2):327\u201338. https:\/\/doi.org\/10.1111\/jgh.13421.","journal-title":"J Gastroenterol Hepatol"},{"key":"2430_CR23","doi-asserted-by":"publisher","first-page":"295153","DOI":"10.1155\/2013\/295153","volume":"2013","author":"CS Kwok","year":"2013","unstructured":"Kwok CS, Krupa L, Mahtani A, Kaye D, Rushbrook SM, Phillips MG, et al. Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis. Biomed Res Int. 2013;2013:295153. https:\/\/doi.org\/10.1155\/2013\/295153.","journal-title":"Biomed Res Int"},{"issue":"2","key":"2430_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","volume":"11","author":"F Salerno","year":"2013","unstructured":"Salerno F, Navickis RJ, Wilkes MM. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol. 2013;11(2):123-130.e121. https:\/\/doi.org\/10.1016\/j.cgh.2012.11.007.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2430_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12876-015-0389-9","volume":"15","author":"F Salerno","year":"2015","unstructured":"Salerno F, Navickis RJ, Wilkes MM. Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis. BMC Gastroenterol. 2015;15:167. https:\/\/doi.org\/10.1186\/s12876-015-0389-9.","journal-title":"BMC Gastroenterol"},{"key":"2430_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004039.pub2","author":"RG Simonetti","year":"2019","unstructured":"Simonetti RG, Perricone G, Nikolova D, Bjelakovic G, Gluud C. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis. Cochrane Database Syst Rev. 2019. https:\/\/doi.org\/10.1002\/14651858.CD004039.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2430_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/1751-2980.12304","volume":"17","author":"TT Guo","year":"2016","unstructured":"Guo TT, Yang Y, Song Y, Ren Y, Liu ZX, Cheng G. Effects of midodrine in patients with ascites due to cirrhosis: systematic review and meta-analysis. J Dig Dis. 2016;17(1):11\u20139. https:\/\/doi.org\/10.1111\/1751-2980.12304.","journal-title":"J Dig Dis"},{"issue":"3","key":"2430_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ygh2.395","volume":"2","author":"AV Kulkarni","year":"2020","unstructured":"Kulkarni AV, Kumar P, Singh S, Sharma M, Talukdar R, Murthy VHV, et al. Prevention of paracentesis-induced circulatory dysfunction\u2014a systematic review and network meta-analysis. GastroHep. 2020;2(3):92\u2013101. https:\/\/doi.org\/10.1002\/ygh2.395.","journal-title":"GastroHep"},{"issue":"8","key":"2430_CR29","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.asjsur.2021.05.040","volume":"44","author":"YJ Zheng","year":"2021","unstructured":"Zheng YJ, Zhuo SJ, Huang B, Su S. A meta-analysis of the efficacy and safety of human serum albumin treatment in patients with ascites due to cirrhosis undergoing drainage. Asian J Surg. 2021;44(8):1116\u20137. https:\/\/doi.org\/10.1016\/j.asjsur.2021.05.040.","journal-title":"Asian J Surg"},{"issue":"19","key":"2430_CR30","doi-asserted-by":"publisher","first-page":"8502","DOI":"10.18632\/aging.102335","volume":"11","author":"Z Bai","year":"2019","unstructured":"Bai Z, Bernardi M, Yoshida EM, Li H, Guo X, M\u00e9ndez-S\u00e1nchez N, et al. Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis. Aging (Albany NY). 2019;11(19):8502\u201325. https:\/\/doi.org\/10.18632\/aging.102335.","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"2430_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.dld.2021.04.030","volume":"53","author":"KB Teh","year":"2021","unstructured":"Teh KB, Loo JH, Tam YC, Wong YJ. Efficacy and safety of albumin infusion for overt hepatic encephalopathy: a systematic review and meta-analysis. Dig Liver Dis. 2021;53(7):817\u201323. https:\/\/doi.org\/10.1016\/j.dld.2021.04.030.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"2430_CR32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/meg.0000000000001932","volume":"33","author":"AA Ashour","year":"2021","unstructured":"Ashour AA, Atta MA, Sadek KW, Obaid KR, Ashour MA, Ashour A, et al. Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update. Eur J Gastroenterol Hepatol. 2021;33(4):479\u201386. https:\/\/doi.org\/10.1097\/meg.0000000000001932.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2430_CR33","doi-asserted-by":"publisher","first-page":"S321","DOI":"10.1007\/s12072-022-10337-4","volume":"16","author":"Z Bai","year":"2022","unstructured":"Bai Z, Wang L, Cheng G, Lin H, Qi X. Use of human serum albumin infusion for the prevention and treatment of hyponatremia in liver cirrhosis: a systematic review and meta-analysis. Hep Intl. 2022;16:S321\u20132. https:\/\/doi.org\/10.1007\/s12072-022-10337-4.","journal-title":"Hep Intl"},{"issue":"10","key":"2430_CR34","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.dld.2020.05.047","volume":"52","author":"YJ Wong","year":"2020","unstructured":"Wong YJ, Qiu TY, Tam YC, Mohan BP, Gallegos-Orozco JF, Adler DG. Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: a systematic review and meta-analysis. Dig Liver Dis. 2020;52(10):1137\u201342. https:\/\/doi.org\/10.1016\/j.dld.2020.05.047.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"2430_CR35","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/hep.26359","volume":"57","author":"BA Runyon","year":"2013","unstructured":"Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57(4):1651\u20133. https:\/\/doi.org\/10.1002\/hep.26359.","journal-title":"Hepatology"},{"issue":"2","key":"2430_CR36","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.31884","volume":"74","author":"SW Biggins","year":"2021","unstructured":"Biggins SW, Angeli P, Garcia-Tsao G, Gin\u00e8s P, Ling SC, Nadim MK, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(2):1014\u201348. https:\/\/doi.org\/10.1002\/hep.31884.","journal-title":"Hepatology"},{"key":"2430_CR37","doi-asserted-by":"publisher","unstructured":"AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis. Dig Liver Dis. 2016;48(1):4\u201315. https:\/\/doi.org\/10.1016\/j.dld.2015.11.008","DOI":"10.1016\/j.dld.2015.11.008"},{"issue":"1","key":"2430_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2450\/2020.0414-20","volume":"19","author":"P Caraceni","year":"2021","unstructured":"Caraceni P, Angeli P, Prati D, Bernardi M, Berti P, Bennardello F, et al. AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update. Blood Transfus. 2021;19(1):9\u201313. https:\/\/doi.org\/10.2450\/2020.0414-20.","journal-title":"Blood Transfus"},{"issue":"2","key":"2430_CR39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.dld.2018.11.035","volume":"51","author":"S Montagnese","year":"2019","unstructured":"Montagnese S, Russo FP, Amodio P, Burra P, Gasbarrini A, Loguercio C, et al. Hepatic encephalopathy 2018: a clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis. 2019;51(2):190\u2013205. https:\/\/doi.org\/10.1016\/j.dld.2018.11.035.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"2430_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/gutjnl-2020-321790","volume":"70","author":"GP Aithal","year":"2021","unstructured":"Aithal GP, Palaniyappan N, China L, H\u00e4rm\u00e4l\u00e4 S, Macken L, Ryan JM, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70(1):9\u201329. https:\/\/doi.org\/10.1136\/gutjnl-2020-321790.","journal-title":"Gut"},{"key":"2430_CR41","doi-asserted-by":"publisher","unstructured":"KASL clinical practice guidelines for liver cirrhosis: ascites and related complications. Clin Mol Hepatol. 2018;24(3):230\u2013277. https:\/\/doi.org\/10.3350\/cmh.2018.1005","DOI":"10.3350\/cmh.2018.1005"},{"key":"2430_CR42","doi-asserted-by":"publisher","unstructured":"KASL clinical practice guidelines for liver cirrhosis: varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol. 2020;26(2):83\u2013127. https:\/\/doi.org\/10.3350\/cmh.2019.0010n","DOI":"10.3350\/cmh.2019.0010n"},{"issue":"1","key":"2430_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-018-09923-2","volume":"13","author":"X Xu","year":"2019","unstructured":"Xu X, Duan Z, Ding H, Li W, Jia J, Wei L, et al. Chinese guidelines on the management of ascites and its related complications in cirrhosis. Hepatol Int. 2019;13(1):1\u201321. https:\/\/doi.org\/10.1007\/s12072-018-09923-2.","journal-title":"Hepatol Int"},{"issue":"4","key":"2430_CR44","doi-asserted-by":"publisher","first-page":"100708","DOI":"10.1016\/j.aohep.2022.100708","volume":"27","author":"G Castro-Narro","year":"2022","unstructured":"Castro-Narro G, Moctezuma-Vel\u00e1zquez C, Male-Vel\u00e1zquez R, Trejo-Estrada R, Bosques FJ, Moreno-Alc\u00e1ntar R, et al. Position statement on the use of albumin in liver cirrhosis. Ann Hepatol. 2022;27(4):100708. https:\/\/doi.org\/10.1016\/j.aohep.2022.100708.","journal-title":"Ann Hepatol"},{"issue":"7","key":"2430_CR45","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/hepr.13678","volume":"51","author":"H Yoshiji","year":"2021","unstructured":"Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res. 2021;51(7):725\u201349. https:\/\/doi.org\/10.1111\/hepr.13678.","journal-title":"Hepatol Res"},{"issue":"Suppl 1","key":"2430_CR46","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","volume":"75","author":"C Engelmann","year":"2021","unstructured":"Engelmann C, Cl\u00e0ria J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75(Suppl 1):S49\u201366. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.002.","journal-title":"J Hepatol"},{"issue":"4","key":"2430_CR47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4254\/wjh.v13.i4.421","volume":"13","author":"YJ Wong","year":"2021","unstructured":"Wong YJ, Kumar R, Chua YJJ, Ang TL. Long-term albumin infusion in decompensated cirrhosis: a review of current literature. World J Hepatol. 2021;13(4):421\u201332. https:\/\/doi.org\/10.4254\/wjh.v13.i4.421.","journal-title":"World J Hepatol"},{"issue":"1","key":"2430_CR48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jhep.2017.01.011","volume":"67","author":"EA Tsochatzis","year":"2017","unstructured":"Tsochatzis EA, Gerbes AL. Diagnosis and treatment of ascites. J Hepatol. 2017;67(1):184\u20135. https:\/\/doi.org\/10.1016\/j.jhep.2017.01.011.","journal-title":"J Hepatol"},{"issue":"10138","key":"2430_CR49","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/s0140-6736(18)30840-7","volume":"391","author":"P Caraceni","year":"2018","unstructured":"Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet. 2018;391(10138):2417\u201329. https:\/\/doi.org\/10.1016\/s0140-6736(18)30840-7.","journal-title":"Lancet"},{"issue":"1","key":"2430_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41395-018-0185-6","volume":"114","author":"D Adebayo","year":"2019","unstructured":"Adebayo D, Neong SF, Wong F. Refractory ascites in liver cirrhosis. Am J Gastroenterol. 2019;114(1):40\u20137. https:\/\/doi.org\/10.1038\/s41395-018-0185-6.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"2430_CR51","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"BA Runyon","year":"2009","unstructured":"Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087\u2013107. https:\/\/doi.org\/10.1002\/hep.22853.","journal-title":"Hepatology"},{"issue":"2","key":"2430_CR52","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","volume":"113","author":"L Ruiz-del-Arbol","year":"1997","unstructured":"Ruiz-del-Arbol L, Monescillo A, Jimen\u00e9z W, Garcia-Plaza A, Arroyo V, Rod\u00e9s J. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology. 1997;113(2):579\u201386. https:\/\/doi.org\/10.1053\/gast.1997.v113.pm9247479.","journal-title":"Gastroenterology"},{"issue":"4","key":"2430_CR53","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.mcna.2008.03.009","volume":"92","author":"SJ Munoz","year":"2008","unstructured":"Munoz SJ. Hepatic encephalopathy. Med Clin N Am. 2008;92(4):795\u2013812, viii. https:\/\/doi.org\/10.1016\/j.mcna.2008.03.009.","journal-title":"Med Clin N Am"},{"key":"2430_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-230x-9-21","volume":"9","author":"G Tarantino","year":"2009","unstructured":"Tarantino G, Citro V, Esposito P, Giaquinto S, de Leone A, Milan G, et al. Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC Gastroenterol. 2009;9:21. https:\/\/doi.org\/10.1186\/1471-230x-9-21.","journal-title":"BMC Gastroenterol"},{"key":"2430_CR55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jcrc.2015.12.019","volume":"33","author":"A Artigas","year":"2016","unstructured":"Artigas A, Wernerman J, Arroyo V, Vincent JL, Levy M. Role of albumin in diseases associated with severe systemic inflammation: pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis. J Crit Care. 2016;33:62\u201370. https:\/\/doi.org\/10.1016\/j.jcrc.2015.12.019.","journal-title":"J Crit Care"},{"issue":"1","key":"2430_CR56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/jhep.2002.30082","volume":"35","author":"J Fern\u00e1ndez","year":"2002","unstructured":"Fern\u00e1ndez J, Navasa M, G\u00f3mez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35(1):140\u20138. https:\/\/doi.org\/10.1053\/jhep.2002.30082.","journal-title":"Hepatology"},{"issue":"6","key":"2430_CR57","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.1840200619","volume":"20","author":"A Follo","year":"1994","unstructured":"Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology. 1994;20(6):1495\u2013501. https:\/\/doi.org\/10.1002\/hep.1840200619.","journal-title":"Hepatology"},{"issue":"6","key":"2430_CR58","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","volume":"129","author":"C Terra","year":"2005","unstructured":"Terra C, Guevara M, Torre A, Gilabert R, Fern\u00e1ndez J, Mart\u00edn-Llah\u00ed M, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology. 2005;129(6):1944\u201353. https:\/\/doi.org\/10.1053\/j.gastro.2005.09.024.","journal-title":"Gastroenterology"},{"issue":"1","key":"2430_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","volume":"4","author":"P Gin\u00e8s","year":"2018","unstructured":"Gin\u00e8s P, Sol\u00e0 E, Angeli P, Wong F, Nadim MK, Kamath PS. Hepatorenal syndrome. Nat Rev Dis Prim. 2018;4(1):23. https:\/\/doi.org\/10.1038\/s41572-018-0022-7.","journal-title":"Nat Rev Dis Prim"},{"key":"2430_CR60","doi-asserted-by":"publisher","first-page":"m2687","DOI":"10.1136\/bmj.m2687","volume":"370","author":"DA Simonetto","year":"2020","unstructured":"Simonetto DA, Gines P, Kamath PS. Hepatorenal syndrome: pathophysiology, diagnosis, and management. BMJ. 2020;370:m2687. https:\/\/doi.org\/10.1136\/bmj.m2687.","journal-title":"BMJ"},{"issue":"4 Pt 1","key":"2430_CR61","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R Ortega","year":"2002","unstructured":"Ortega R, Gin\u00e8s P, Uriz J, C\u00e1rdenas A, Calahorra B, De Las HD, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002;36(4 Pt 1):941\u20138. https:\/\/doi.org\/10.1053\/jhep.2002.35819.","journal-title":"Hepatology"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02430-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02430-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02430-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:36:53Z","timestamp":1680518213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02430-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2430"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02430-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}